Crossingbridge Advisors’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Crossingbridge Advisors’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,418	Closed	-$1.42K	–	121
2025 Q1	$1.42K	Buy	+1,418	New	+$1.42K	﹤0.01%	88

Crossingbridge Advisors's VAXX Position: Q2 2025 in Review

Crossingbridge Advisors sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2025, closing a stake of 1,418 shares — an estimated $1.42K sold.

Crossingbridge Advisors first reported a position in VAXX in Q1 2025 and held it in 1 quarter. The position peaked at $1.42K in Q1 2025. 0 funds tracked by Wall St. Rank hold VAXX as of Q2 2025.

Crossingbridge Advisors reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2025 after selling out during the quarter.
Crossingbridge Advisors sold 1,418 Vaxxinity, Inc. Class A Common Stock shares in Q2 2025, an estimated $1.42K.
Crossingbridge Advisors first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2025 and held it in 1 quarter.
Crossingbridge Advisors's Vaxxinity, Inc. Class A Common Stock position peaked at $1.42K in Q1 2025.
0 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2025.

Based on Crossingbridge Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.